Carregant...
Advances in the understanding and management of T-cell prolymphocytic leukemia
T-prolymphocytic leukemia (T-PLL) is a rare T-cell neoplasm with an aggressive clinical course. Leukemic T-cells exhibit a post-thymic T-cell phenotype (Tdt(−), CD1a(−), CD5(+), CD2(+) and CD7(+)) and are generally CD4(+)/CD8(−), but CD4(+)/CD8(+) or CD8(+)/CD4(−) T-PLL have also been reported. The...
Guardat en:
| Publicat a: | Oncotarget |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Impact Journals LLC
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5732835/ https://ncbi.nlm.nih.gov/pubmed/29262669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22272 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|